Trials / Completed
CompletedNCT02231671
A Phase 1, Open-Label Study of the Absorption, Metabolism, Excretion and Absolute Bioavailability of ALS-008176
A Phase 1, Open-Label Study of the Absorption, Metabolism, Excretion and Absolute Bioavailability of 14C-ALS-008176 in Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Alios Biopharma Inc. · Industry
- Sex
- Male
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to see how ALS-008176 is taken up, broken down, and removed from the body.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ALS-008176 | |
| DRUG | ALS-008112 |
Timeline
- Start date
- 2014-08-31
- Primary completion
- 2014-09-30
- Completion
- 2014-11-30
- First posted
- 2014-09-04
- Last updated
- 2017-10-31
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02231671. Inclusion in this directory is not an endorsement.